Literature DB >> 11219777

Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.

W Zheng1, D Xie, J R Cerhan, T A Sellers, W Wen, A R Folsom.   

Abstract

Sulfotransferase (SULT) 1A1 is involved in the inactivation of estrogens and bioactivation of heterocyclic amines and polycyclic aromatic hydrocarbons. A G--->A transition at codon 213 (CGC/Arg to CAC/His) of the SULT1A1 gene was reported recently, and individuals homozygous for the His allele have a substantially lower activity of this enzyme than those with other genotypes. We hypothesized that the His allele may be a risk factor for breast cancer, particularly among women who had risk factors related to higher endogenous estrogen exposure. This hypothesis was investigated in a case-control study conducted in a cohort of postmenopausal Iowa women who completed a mailed questionnaire in 1986 on lifestyle factors including information on major breast cancer risk factors. DNA samples and information related to well-done meat intake were obtained from breast cancer cases diagnosed between 1992 and 1994 and a random sample of cancer-free cohort members. Multivariate analysis was performed on data from 156 cases and 332 controls who donated a blood sample. The frequency of the His allele was 41.6% in cases and 34.1% in controls (P = 0.03), and the risk of breast cancer was increased with the number of His alleles (P for trend = 0.02). Compared with women with the Arg/Arg genotype, an 80% elevated risk was observed among women homozygous for the His allele (95% confidence interval, 1.0-3.2; P = 0.04). This positive association was more pronounced among women who drank alcohol and had a high body mass index, early age at menarche, and late age at menopause, factors related to high endogenous estrogen exposure, than among those who did not have these risk factors. The risk of breast cancer was elevated with increasing doneness level of red meat intake among women with the Arg/Arg genotype (P for trend, 0.01) or the Arg/His genotype (P for trend, 0.10), whereas this association was not evident for women with the His/His genotype. The results from this study suggest that homozygosity for the SULT1A1 His213 allele may be a risk factor for breast cancer, and its effect may be modified by the exposure level of endogenous estrogens and heterocyclic amines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11219777

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  27 in total

1.  DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry.

Authors:  Dan Gu; Robert J Turesky; Yeqing Tao; Sophie A Langouët; Gwendoline C Nauwelaërs; Jian-Min Yuan; Douglas Yee; Mimi C Yu
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  Oligogenic combinations associated with breast cancer risk in women under 53 years of age.

Authors:  Christopher E Aston; David A Ralph; Dominique P Lalo; Sharmila Manjeshwar; Bobby A Gramling; Daniele C DeFreese; Amy D West; Dannielle E Branam; Linda F Thompson; Melissa A Craft; Debra S Mitchell; Craig D Shimasaki; John J Mulvihill; Eldon R Jupe
Journal:  Hum Genet       Date:  2004-12-21       Impact factor: 4.132

3.  Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population.

Authors:  Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki
Journal:  Int Urol Nephrol       Date:  2008-03-27       Impact factor: 2.370

4.  Sulfotransferase 1A1 Arg(213)His polymorphism and prostate cancer risk.

Authors:  Serdal Arslan; Yavuz Silig; Hatice Pinarbasi
Journal:  Exp Ther Med       Date:  2011-08-12       Impact factor: 2.447

5.  A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer.

Authors:  Stefania Boccia; Gabriella Cadoni; Giuseppe La Torre; Dario Arzani; Mariangela Volante; Caterina Cattel; Francesco Gianfagna; Gaetano Paludetti; Giovanni Almadori; Gualtiero Ricciardi
Journal:  J Cancer Res Clin Oncol       Date:  2006-03-31       Impact factor: 4.553

Review 6.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

7.  Relationship of SULT1A1 copy number variation with estrogen metabolism and human health.

Authors:  Jixia Liu; Ran Zhao; Zhan Ye; Alexander J Frey; Emily R Schriver; Nathaniel W Snyder; Scott J Hebbring
Journal:  J Steroid Biochem Mol Biol       Date:  2017-09-01       Impact factor: 4.292

Review 8.  Well-done meat intake, heterocyclic amine exposure, and cancer risk.

Authors:  Wei Zheng; Sang-Ah Lee
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

9.  Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue.

Authors:  Yiwei Jiang; Liheng Zhou; Tingting Yan; Zhenzhou Shen; Zhimin Shao; Jinsong Lu
Journal:  J Exp Clin Cancer Res       Date:  2010-07-21

Review 10.  Pharmacogenetics of soluble sulfotransferases (SULTs).

Authors:  Hansruedi Glatt; Walter Meinl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.